Infectious Disease

Top Story

FDA designates topical antifungal treatment as QIDP

FDA designates topical antifungal treatment as QIDP
May 31, 2016

The FDA has designated Cidara Therapeutics’ topical antifungal treatment as a qualified infectious disease product and granted fast track status for its development, the company announced today.

CD101 topical is used for the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent VVC infections, the release said. The drug has previously demonstrated broad-spectrum activity against Candida species. It will be further evaluated this year in the RADIANT study — a phase 2 comparative clinical trial.

FDA News

FDA expands indication of Teflaro for pediatric patients with CABP, ABSSSIs

May 31, 2016
The FDA has expanded the indication for Teflaro, an injectable antibiotic in the cephalosporin class, to treat pediatric patients aged 2 months to 18 years with…

WHO supports holding Olympics in Brazil despite concerns of Zika virus

May 31, 2016
WHO reported that there is no need to change the location of the 2016 Summer Olympics, as holding the games in Rio de Janeiro will not have a significant impact on the…
In the Journals

Sovaldi, Harvoni unaffordable in various countries

May 31, 2016
A global economic analysis of pricing of a 12-week duration of treatment with Sovaldi or Harvoni in 30 countries indicated prices varied according to country wealth and…
Meeting News CoverageVideo

VIDEO: Expert recaps new FMT data presented at DDW

May 31, 2016
SAN DIEGO — In this exclusive video from DDW, Colleen R. Kelly, MD, from Brown University and the Center for Women’s GI Medicine in Providence, Rhode…
More News Headlines »
CME

Proper Immunization of the Adolescent Patient

No commercial support for this activity.

Prior to 2005, the tetanus and diphtheria toxoids (Td) booster was the sole vaccine routinely recommended for healthy…
More »
Video

VIDEO: Patients with HIV, HCV face risk for re-infection following antiviral treatment

May 27, 2016
More »
Featured
Zika Resource Center

Zika Resource Center

CME

Operation Immunization 2016: Enhancing HPV Immunization

This activity is supported by an educational grant from Merck & Co., Inc.

During the last decade, several new vaccines, including the meningococcal conjugate (MCV4), tetanus, diphtheria…
More »
morganatic-roan